IZOTROPIC CORP. Total Assets
IZOTROPIC CORP. total assets. Based on the latest financial reports, IZOTROPIC CORP. (1R3) holds total assets worth €439.78K EUR (≈ $514.15K USD) as of April 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see IZOTROPIC CORP. (1R3) total market value for the company's overall valuation and market capitalisation.
Total Assets of IZOTROPIC CORP. (2022–2026)
Total assets of IZOTROPIC CORP. from 2022 to 2026. This chart illustrates how IZOTROPIC CORP.'s total assets have evolved over time, based on quarterly financial data. See IZOTROPIC CORP. stock price for real-time trading data and today's change.
IZOTROPIC CORP. - Asset Composition Analysis
IZOTROPIC CORP. Total Assets Breakdown (April 2026)
IZOTROPIC CORP. total assets breakdown as of April 2026. IZOTROPIC CORP.'s total assets of €439.78K consist of 75.1% current assets and 24.9% non-current assets.
| Asset Category | Amount (EUR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 50.0% |
| Accounts Receivable | €0.00 | 0.0% |
| Inventory | €0.00 | 0.0% |
| Property, Plant & Equipment | €0.00 | 0.0% |
| Intangible Assets | €0.00 | 0.0% |
| Goodwill | €0.00 | 0.0% |
Asset Composition Trend (2022–2026)
This chart illustrates how IZOTROPIC CORP.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore working capital to net assets of IZOTROPIC CORP. to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: IZOTROPIC CORP.'s current assets represent 75.1% of total assets in 2026, a decrease from 99.2% in 2022.
- Cash Position: Cash and equivalents constituted 50.0% of total assets in 2026, down from 81.8% in 2022.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2022.
- Asset Diversification: The largest asset category is goodwill at 0.0% of total assets.
IZOTROPIC CORP. Competitors by Total Assets
Key competitors of IZOTROPIC CORP. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Revvity Inc.
NYSE:RVTY
|
USA | $12.00 Billion |
|
Sonic Healthcare Ltd
AU:SHL
|
Australia | AU$16.78 Billion |
|
Guangzhou Kingmed Diagnostics Group Co Ltd
SHG:603882
|
China | CN¥9.20 Billion |
|
INOVIQ LTD.
F:EGQ0
|
Germany | €21.71 Million |
|
Avricore Health Inc
V:AVCR
|
Canada | CA$584.37K |
|
Integral Diagnostics Ltd
AU:IDX
|
Australia | AU$1.43 Billion |
|
Australian Clinical Labs Ltd
AU:ACL
|
Australia | AU$562.50 Million |
|
Healius Ltd
AU:HLS
|
Australia | AU$1.77 Billion |
IZOTROPIC CORP. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.06 | 0.08 | 0.05 |
| Quick Ratio | 0.06 | 0.08 | 0.05 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | €-5.66 Million | €-4.88 Million | €-4.33 Million |
IZOTROPIC CORP. - Advanced Valuation Insights
This section examines the relationship between IZOTROPIC CORP.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 99.59 |
| Latest Market Cap to Assets Ratio | 14.63 |
| Asset Growth Rate (YoY) | 6.0% |
| Total Assets | €439.78K |
| Market Capitalization | $6.44 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values IZOTROPIC CORP.'s assets at a significant premium (14.63x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: IZOTROPIC CORP.'s assets grew by 6.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for IZOTROPIC CORP. (2022–2026)
The table below shows the annual total assets of IZOTROPIC CORP. from 2022 to 2026.
| Year | Total Assets | Change |
|---|---|---|
| 2026-04-30 | €439.78K ≈ $514.15K |
+6.04% |
| 2025-04-30 | €414.73K ≈ $484.86K |
+78.47% |
| 2024-04-30 | €232.38K ≈ $271.67K |
-47.44% |
| 2023-04-30 | €442.11K ≈ $516.88K |
-80.52% |
| 2022-04-30 | €2.27 Million ≈ $2.65 Million |
-- |
About IZOTROPIC CORP.
Izotropic Corporation, a research and development company, develops diagnostic products for detecting breast cancers. It develops and commercializes IzoView, a breast CT imaging system. The company was incorporated in 2016 and is headquartered in Surrey, Canada.